• 1
    Lacey JV Jr, Devesa SS & Brinton LA (2002) Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen 39, 8288.
  • 2
    Ying L, Chen Q, Wang Y, Zhou Z, Huang Y & Qiu F (2012) Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol BioSyst 8, 22892294.
  • 3
    Egerod FL, Bartels A, Fristrup N, Borre M, Orntoft TF, Oleksiewicz MB, Brunner N & Dyrskjot L (2009) High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression. BMC Cancer 9, 385.
  • 4
    Bo J, Yang G, Huo K, Jiang H, Zhang L, Liu D & Huang Y (2011) microRNA-203 suppresses bladder cancer development by repressing bcl-w expression. FEBS J 278, 786792.
  • 5
    Said N, Sanchez-Carbayo M, Smith SC & Theodorescu D (2012) RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration. J Clin Invest 122, 15031518.
  • 6
    Kapinas K, Kessler CB, Ricks T, Gronowicz G & Delany AM (2010) miR-29 modulates WNT signaling in human osteoblasts through a positive feedback loop. J Biol Chem 285, 2522125231.
  • 7
    Mizuno Y, Yagi K, Tokuzawa Y, Kanesaki-Yatsuka Y, Suda T, Katagiri T, Fukuda T, Maruyama M, Okuda A, Amemiya T et al. (2008) miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem Biophys Res Commun 368, 267272.
  • 8
    Wang T & Xu Z (2010) miR-27 promotes osteoblast differentiation by modulating Wnt signaling. Biochem Biophys Res Commun 402, 186189.
  • 9
    Zhang Y, Wei W, Cheng N, Wang K, Li B, Jiang X & Sun S (2012) Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology 56, 16311640.
  • 10
    Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH, Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX et al. (2012) The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 61, 278289.
  • 11
    Zhang LY, Ho-Fun Lee V, Wong AM, Kwong DL, Zhu YH, Dong SS, Kong KL, Chen J, Tsao SW, Guan XY et al. (2013) MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Carcinogenesis 34, 454463.
  • 12
    Iwaya T, Yokobori T, Nishida N, Kogo R, Sudo T, Tanaka F, Shibata K, Sawada G, Takahashi Y, Ishibashi M et al. (2012) Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway. Carcinogenesis 33, 23912397.
  • 13
    Qi W, Chan H, Teng L, Li L, Chuai S, Zhang R, Zeng J, Li M, Fan H, Lin Y et al. (2012) Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation. Proc Natl Acad Sci USA 109, 2136021365.
  • 14
    Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, Jones RS & Zhang Y (2002) Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298, 10391043.
  • 15
    Ren G, Baritaki S, Marathe H, Feng J, Park S, Beach S, Bazeley PS, Beshir AB, Fenteany G, Mehra R et al. (2012) Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Cancer Res 72, 30913104.
  • 16
    Wang H, Albadine R, Magheli A, Guzzo TJ, Ball MW, Hinz S, Schoenberg MP, Netto GJ & Gonzalgo ML (2012) Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder. Urol Oncol 30, 428433.
  • 17
    Wang X, Wang H, Bu R, Fei X, Zhao C & Song Y (2012) Methylation and aberrant expression of the Wnt antagonist secreted Frizzled-related protein 1 in bladder cancer. Oncol Lett 4, 334338.
  • 18
    Koch A, Waha A, Hartmann W, Hrychyk A, Schuller U, Wharton KA Jr, Fuchs SY, von Schweinitz D & Pietsch T (2005) Elevated expression of Wnt antagonists is a common event in hepatoblastomas. Clin Cancer Res 11, 42954304.
  • 19
    Huang L, Luo J, Cai Q, Pan Q, Zeng H, Guo Z, Dong W, Huang J & Lin T (2011) MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Int J Cancer 128, 17581769.
  • 20
    Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, Nishiyama K, Fujimura L, Kikkawa N, Seki N & Nakagawa M (2010) miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 102, 883891.
  • 21
    Chiang Y, Song Y, Wang Z, Chen Y, Yue Z, Xu H, Xing C & Liu Z (2010) Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers. J Gastrointest Surg 15, 6370.
  • 22
    Noguchi S, Yasui Y, Iwasaki J, Kumazaki M, Yamada N, Naito S & Akao Y (2013) Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways. Cancer Lett 328, 353361.
  • 23
    Chang CJ & Hung MC (2012) The role of EZH2 in tumour progression. Br J Cancer 106, 243247.
  • 24
    Cheng AS, Lau SS, Chen Y, Kondo Y, Li MS, Feng H, Ching AK, Cheung KF, Wong HK, Tong JH et al. (2011) EZH2-mediated concordant repression of Wnt antagonists promotes beta-catenin-dependent hepatocarcinogenesis. Cancer Res 71, 40284039.
  • 25
    Wang L, Jin Q, Lee JE, Su IH & Ge K (2010) Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis. Proc Natl Acad Sci USA 107, 73177322.
  • 26
    Wu Y & Zhou BP (2008) New insights of epithelial–mesenchymal transition in cancer metastasis. Acta Biochim Biophys Sin (Shanghai) 40, 643650.
  • 27
    Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR et al. (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33, e179.
  • 28
    Qin W, Shi Y, Zhao B, Yao C, Jin L, Ma J & Jin Y (2010) miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells. PLoS One 5, e9429.
  • 29
    Tano K, Mizuno R, Okada T, Rakwal R, Shibato J, Masuo Y, Ijiri K & Akimitsu N (2010) MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett 584, 45754580.
  • 30
    Xu N, Shen C, Luo Y, Xia L, Xue F, Xia Q & Zhang J (2012) Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell. Biochem Biophys Res Commun 425, 468472.